These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1199972)

  • 1. Detection of fibrin degradation products. A simplified technic.
    Eipe J; Yakulis V; Costea N
    Am J Clin Pathol; 1975 Oct; 64(4):509-11. PubMed ID: 1199972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of the use of glutaraldehyde for the sensitization of red cells in Merskey's technic].
    Quichaud C; de Cacqueray-Joigny C; Etcharry F; Moras M; Chatelan M; Boisseau M; Bentegeat J
    Pathol Biol (Paris); 1974 Nov; 22 suppl():92-6. PubMed ID: 4219981
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of serum fibrinogen degradation products using Merskey's technic, Apropos of 169 cases].
    Kolodié L; Seigneurin D; Micouin C; Hollard D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():66-71. PubMed ID: 4219980
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
    Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
    Lab Delo; 1978; (5):259-66. PubMed ID: 79007
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum.
    Ratky SM; Martin MJ; Gordon YB; Baker LR; Chard T; Leslie J
    Br J Haematol; 1975 Jun; 30(2):145-9. PubMed ID: 1201206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum and urinary fibrin/fibrinogen degradation products (FDP) in patients with urologic malignancies (author's transl)].
    Ohtaki M
    Nihon Hinyokika Gakkai Zasshi; 1977 Dec; 68(12):1172-83. PubMed ID: 609173
    [No Abstract]   [Full Text] [Related]  

  • 9. False-negative test for fibrinogen--fibrin degradation products.
    Kickler T; Bell WR
    Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
    Sumner K; Feller E; Galanakis DK; Mosesson MW
    Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of fibrinogen degradation products (FDP) in serum of normal and tumor-bearing rats.
    Abe K; Fujimoto H; Endo E; Fukuoka Y; Khato J
    Tohoku J Exp Med; 1975 Dec; 117(4):343-50. PubMed ID: 174248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of fibrin degradation products. A comparison of counterimmunoelectrophoresis and two hemagglutination-inhibition methods.
    Ferguson AC; Kennedy H; Ank BJ; Sturgeon P; Stiehm ER
    Am J Clin Pathol; 1974 Dec; 62(6):861-8. PubMed ID: 4473890
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinogenderivatives in plasma and serum of newborn infants with respiratory distress syndrome].
    Lenk H; Weissbach G; Braun W; Domula M; Vogtmann C
    Acta Paediatr Acad Sci Hung; 1976; 17(2):135-46. PubMed ID: 1032734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological assay and radioimmunoassay of FDP on human serum (author's transl)].
    Abe K
    Rinsho Byori; 1978; 26(4):313-21. PubMed ID: 671777
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.
    Das PC
    J Clin Pathol; 1970 May; 23(4):299-303. PubMed ID: 5464330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple passive hemagglutination-inhibition technic for determination of fibrin degradation products and fibrinogen.
    Petchclai B; Prasongsom S
    Am J Clin Pathol; 1974 Feb; 61(2):166-8. PubMed ID: 4204530
    [No Abstract]   [Full Text] [Related]  

  • 19. [The detection of serum and urine fibrin and fibrinogen degradation products by hemagglutination inhibition test (author's transl)].
    Wang Z
    Zhonghua Nei Ke Za Zhi; 1979; 18(5):330-3. PubMed ID: 555935
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of fibrinogen/fibrin degradation products and soluble fibrin complexes for differentiating pulmonary embolism from nonthromboembolic lung disease.
    Bynum LJ; Crotty C; Wilson JE
    Am Rev Respir Dis; 1976 Aug; 114(2):285-9. PubMed ID: 973720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.